SteelPeak Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Sell
2,493
-122,710
-98% -$16.2M 0.01% 513
2026
Q1
$17.4M Buy
+125,203
New +$17.5M 0.53% 44
2025
Q4
Sell
-5,158
Closed -$573K 582
2025
Q3
$573K Sell
5,158
-94,279
-95% -$10.7M 0.02% 370
2025
Q2
$11M Sell
99,437
-29,749
-23% -$3.17M 0.43% 56
2025
Q1
$14.5M Buy
129,186
+75,912
+142% +$7.83M 0.6% 37
2024
Q4
$4.92M Buy
+53,274
New +$4.8M 0.2% 94
2024
Q2
Sell
-112,617
Closed -$8.25M 560
2024
Q1
$8.25M Buy
112,617
+18,349
+19% +$1.41M 0.42% 58
2023
Q4
$7.64M Buy
94,268
+71,195
+309% +$5.54M 0.44% 61
2023
Q3
$1.73M Buy
+23,073
New +$1.77M 0.11% 138
2023
Q2
Sell
-179,813
Closed -$14.9M 468
2023
Q1
$14.9M Buy
179,813
+72,860
+68% +$6.03M 1.01% 26
2022
Q4
$9.18M Sell
106,953
-35,852
-25% -$2.84M 0.67% 39
2022
Q3
$8.81M Buy
142,805
+135,277
+1,797% +$8.53M 0.66% 45
2022
Q2
$465K Buy
7,528
+2,354
+45% +$146K 0.03% 261
2022
Q1
$307K Sell
5,174
-31,824
-86% -$2.03M 0.02% 350
2021
Q4
$2.69M Buy
36,998
+32,225
+675% +$2.22M 0.15% 104
2021
Q3
$333K Sell
4,773
-839
-15% -$58.9K 0.02% 314
2021
Q2
$386K Buy
5,612
+671
+14% +$44.8K 0.03% 298
2021
Q1
$319K Sell
4,941
-22,454
-82% -$1.45M 0.03% 292
2020
Q4
$1.6M Sell
27,395
-57,552
-68% -$3.47M 0.15% 115
2020
Q3
$5.37M Buy
84,947
+3,194
+4% +$221K 0.58% 46
2020
Q2
$6.29M Buy
81,753
+75,285
+1,164% +$5.77M 0.79% 26
2020
Q1
$484K Sell
6,468
-26,948
-81% -$1.86M 0.08% 152
2019
Q4
$2.17M Buy
+33,416
New +$2.18M 0.3% 73

Other funds holding GILD

SteelPeak Wealth's GILD Position: Q2 2026 in Review

SteelPeak Wealth reduced its Gilead Sciences (GILD) stake by 98% in Q2 2026, selling an estimated $16.2M and leaving 2,493 shares worth $315K. The position accounts for 0.01% of the portfolio, ranked #513.

SteelPeak Wealth first reported a position in GILD in Q4 2019 and has held it in 23 quarters since. The position peaked at $17.4M in Q1 2026. 610 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SteelPeak Wealth held 2,493 shares of Gilead Sciences worth $315K as of Q2 2026.
  • SteelPeak Wealth sold 122,710 Gilead Sciences shares in Q2 2026, an estimated $16.2M.
  • Gilead Sciences made up 0.01% of SteelPeak Wealth's portfolio in Q2 2026, its #513 holding.
  • SteelPeak Wealth first reported a position in Gilead Sciences in Q4 2019 and has held it in 23 quarters since.
  • SteelPeak Wealth's Gilead Sciences position peaked at $17.4M in Q1 2026.
  • 610 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.